Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03188588

Acronym

ObsO2

Enrollment

120

Registered

2017-06-15

Start date

2017-01-31

Completion date

2020-01-01

Last updated

2020-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Respiratory Disease, Hypoxemia

Brief summary

Long-term oxygen therapy (LTOT) is the reference treatment for chronic respiratory failure. This treatment is based on the principle of oxygen supplementation via a source to correct hypoxemia in patients. At present, adherence to this treatment is difficult to evaluate (reporting by patients), but the results of the literature show poor LTOT compliance. It is therefore important to accurately measure the oxygen consumption by patients and to understand the factors explaining LTOT compliance. The ultimate aim is to improve our patient management to make them more observant in order to improve the therapeutic efficacy of the treatment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* chronic respiratory disease patients with chronic hypoxemia * First prescribed long term oxygenotherapy

Exclusion criteria

* patients with NIV and CPAP * vital pronostic \< 3 months

Design outcomes

Primary

Measure	Time frame	Description
oxygen use	6 month	time of oxygen use

Secondary

Measure	Time frame
precarity score assessed by a questionnaire (EPICE)	baseline
respiratory disease severity based on GOLD standards	baseline
quality of life assessed by a questionnaire (VQ-11)	baseline, 3 month and 6 month

Countries

France

Outcome results